Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-18-013423
Filing Date
2018-03-14
Accepted
2018-03-14 15:18:52
Documents
66
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10k.htm 10-K 1551215
2 EXHIBIT 14.1 ex14_1.htm EX-14.1 65559
3 EXHIBIT 21.1 ex21_1.htm EX-21.1 1600
4 EXHIBIT 23.1 ex23_1.htm EX-23.1 3461
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 11970
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 4990
13 image00001.jpg GRAPHIC 27626
  Complete submission text file 0001140361-18-013423.txt   5920312

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bstc-20171231.xml EX-101.INS 1021854
8 XBRL TAXONOMY EXTENSION SCHEMA bstc-20171231.xsd EX-101.SCH 40775
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20171231_cal.xml EX-101.CAL 48681
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20171231_def.xml EX-101.DEF 174763
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20171231_lab.xml EX-101.LAB 628772
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20171231_pre.xml EX-101.PRE 351520
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34236 | Film No.: 18689308
SIC: 2834 Pharmaceutical Preparations